Le vote final aura lieu lors de la session plénière de Bruxelles les 25 et 26 mars.
The post Le Parlement européen envisage une date pour se prononcer sur l’accord commercial avec les États-Unis, mettant fin à l’impasse appeared first on Euractiv FR.
Following the DROI public hearing on 'The EU strategy to promote and to protect human rights of women worldwide (notably fighting gender apartheid in Afghanistan & Iran)', in September 2025, DROI discusses the current situation of human rights in the country, which has been radically deteriorated under Taliban regime.
Taliban regime has banned women and girls from education and imposed unbearable barriers to their fundamental rights of freedom of speech, assembly, movement and work. Prosecution against HRDs and activists and journalists has been intensified. The regime extensively practices torture and ill-treatment, extrajudicial killings and corporal punishments. A severe economic and humanitarian crisis hits the Afghan people, mostly vulnerable groups, refugees and social minorities.
L'exécutif européen doit se prononcer ce mois-ci sur l'avenir de l'élevage d'animaux à fourrure.
The post L’Autriche fait pression pour l’interdiction des fourrures dans l’UE avant la décision de la Commission appeared first on Euractiv FR.
L'UE débat actuellement pour savoir si elle doit dévoiler sa nouvelle stratégie de sécurité avant ou après le sommet de l'OTAN prévu en juillet.
The post L’UE débat du moment opportun pour dévoiler sa nouvelle stratégie de sécurité appeared first on Euractiv FR.
Written by Laurence Amand-Eeckhout.
CONTEXTOn 16 December 2025, the European Commission put forward a proposal for a regulation to simplify the rules governing medical devices in the EU. The proposal forms part of a broader package of measures aimed at improving citizens’ health and strengthening the resilience and competitiveness of the health sector. An evaluation of the current EU regulatory framework for medical devices concluded that it has led to unnecessary costs, administrative bottlenecks, regulatory uncertainty for companies, and delays in patient access to medical devices. The proposed revision seeks to address these challenges while ensuring that patient safety remains the highest priority, with faster access to safe and innovative devices. It also aims to reinforce the EU’s competitiveness in the medical technology sector, by establishing a more coherent framework enabling companies to better respond to evolving market conditions, technological developments and patient needs.
LEGISLATIVE PROPOSAL2025/0404(COD) – Proposal for a regulation of the European Parliament and of the Council amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I – COM(2025) 1023, 16 December 2025.
NEXT STEPS IN THE EUROPEAN PARLIAMENTFor the latest developments in this legislative procedure, see the Legislative Train Schedule: 2025/0404(COD)
Read the complete briefing on ‘Medical devices: Simplifying the rules‘ in the Think Tank pages of the European Parliament.